NFL Biosciences SA (EPA:ALNFL)
France
· Delayed Price · Currency is EUR 1.078
+0.006 (0.56%)
At close: Mar 6, 2026
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €13.66 million as of March 6, 2026. Its market cap has decreased by -19.39% in one year.
Market Cap
13.66M
Enterprise Value
11.59M
Revenue
164.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.08
Market Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 13.66M, a decrease of -29.85%. That is a compound annual growth rate of -7.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.66M | -8.49% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poxel | 13.38M |
| Aelis Farma | 16.31M |
| Oncodesign Precision Medicine Société anonyme | 10.62M |
| GenSight Biologics | 20.29M |
| Plant Advanced Technologies | 8.98M |
| genOway Société anonyme | 21.11M |
| Advicenne | 27.34M |
| TME Pharma | 6.64M |